Country’s leading pharma manufacturer Beximco Pharmaceuticals Ltd makes a foray into Australian Pharma market with the launch of Pantoprazole, a drug for treating gastrointestinal disorder. This is for the first time pharmaceutical product from Bangladesh is being exported to Australia.
Beximco Pharmaceuticals Limited (“BPL” or “Company”; AIM Symbol: BXP), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, today announces that it has received GMP (Good Manufacturing Practices) approval from the Canadian regulatory authority, Health Canada. Beximco Pharma is the first Bangladeshi company to receive GMP accreditation from Health Canada.
The US Ambassador to Bangladesh, His Excellency Dan W. Mozena, visited the state-of-the-art manufacturing facilities of Beximco Pharmaceuticals Ltd. (BPL) at Tongi on November 4, 2014 (Tuesday). He was accompanied by Daniel Keen, Economic Commercial Officer and other officials of the Embassy.
Beximco Pharmaceuticals Limited (“BPL” or “the Company”), the fast-growing manufacturer of generic pharmaceutical formulation products, active pharmaceutical ingredients and intravenous fluids, today announces that it has received GMP (“Good Manufacturing Practices”) accreditation from Taiwan Food and Drug Administration (TFDA) as the first Bangladeshi company. The company has received the approval for its oral solid, Inhaler and sterile eye drop facilities.
Mr. Mahbubul Alam, Independent Director of Beximco Pharmaceuticals Ltd., passed away on Friday 6th June, 2014. He had served as a Non-Executive Independent Director of the Company from March 2014. Additionally, he was the Chairman of the Audit Committee.
Mr. Mohammad Abul Qasem, Director of Beximco Pharmaceuticals Ltd., passed away on April 19, 2014 at a local hospital in Dhaka. He was 85. He left behind his wife, three sons and one daughter.
Beximco Pharmaceuticals Limited (“Beximco Pharma”, “BPL” or “the Company”; AIM Symbol: BXP), the fast-growing manufacturer of generic pharmaceutical products and active pharmaceutical ingredients, is pleased to announce that Daniel Stewart & Company plc (“Daniel Stewart”) has been appointed as Nominated Adviser to the Company with immediate effect. Daniel Stewart will continue to act as the Company′s Sole Broker.
Beximco Pharmaceuticals Ltd. has won the prestigious Asia's Most Promising Brand award at the Asian Brand & Leadership Summit 2013 held during 26-27 August, 2013 in Dubai. Beximco Pharma ranked among Top 30 from among 200 emerging brands in Asia. It also received Industry's #1 award in pharma category. Beximco Pharma COO Mr. Rabbur Reza received the award at a gala ceremony held on 27 August in Dubai. Company’s Managing Director, Nazmul Hassan MP received the Asia’s Most Influential Leader award for his outstanding leadership and contribution to business and economic growth in the country as well as in the region.
Delegation from United Kingdom Royal College of Defense Studies (RCDS) headed by Air Commodore Steve Abbott and Colonel Darrel Amison, visited the state-of-the-art manufacturing facility of Beximco Pharmaceuticals Ltd. (“BPL” or the “Company”) at Tongi on 26th May 2013, a company statement said today. He was accompanied by Lt. Col. Stuart Cattermull, Defense Advisor of the British High Commission of Dhaka.